FDA-Drug2020-12-30Class II
Auryxia (ferric citrate) tablets, 210 mg, 200-count bottles, Rx only, Manufactured for and distributed by: KERYX BIOPHARMACEUTICALS, INC., One Marina Park Drive, 12th Floor, Boston, MA 02210, NDC 59922-631-01
Akebia Therapeutics dba Keryx Biopharmaceutials, Inc
Hazard
CGMP Deviations
Sold states
The product was distributed by two major distributors who further distributed the product nationwide and one specialty pharmacy.
Affected count
2,170 bottles
Manufactured in
245 1st St, N/A, Cambridge, MA, United States
Products
Auryxia (ferric citrate) tablets, 210 mg, 200-count bottles, Rx only, Manufactured for and distributed by: KERYX BIOPHARMACEUTICALS, INC., One Marina Park Drive, 12th Floor, Boston, MA 02210, NDC 59922-631-01
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0170-2021Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief